§ 13F · FUND PROFILE
Vestal Point Capital, LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 90Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$859M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines Inc | 2.38M | $231M | 6.5% | +705% |
| 2 | BMRN | BioMarin Pharmaceutical Inc | 3.58M | $202M | 5.6% | +19% |
| 3 | ABVX | Abivax SA | 1.50M | $167M | 4.7% | −21% |
| 4 | NBIX | Neurocrine Biosciences Inc | 1.25M | $165M | 4.6% | NEW |
| 5 | ARWR | Arrowhead Pharmaceuticals Inc | 2.27M | $143M | 4.0% | +153% |
| 6 | ELVN | Enliven Therapeutics Inc | 3.25M | $127M | 3.6% | −15% |
| 7 | RGEN | Repligen Corp | 925K | $109M | 3.0% | +1014% |
| 8 | BCAX | Bicara Therapeutics Inc | 5.42M | $108M | 3.0% | +52% |
| 9 | NRIX | Nurix Therapeutics Inc | 6.50M | $101M | 2.8% | +39% |
| 10 | APGE | Apogee Therapeutics Inc | 1.10M | $93M | 2.6% | +100% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE VESTAL SIGNAL
AC read
Vestal Point Capital, LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed